News Quantified

MTNB – matinas biopharma holdings, inc. (US:NASDAQ)

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Form 8-K Matinas BioPharma Holdin For: Nov 18

Form SCHEDULE 13G/A Matinas BioPharma Holdin Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC

Form 10-Q Matinas BioPharma Holdin For: Sep 30

Form SCHEDULE 13D/A Matinas BioPharma Holdin Filed by: Hezbay Holdings LLC

Top News Decliners

7/25 Matinas BioPharma Receives Qualified Infectious Disease Product (QIDP) and Fast Track Designations From U.S. FDA for MAT2203 for the Treatment of Cryptococcal Meningitis -14.0%

1/9 Form 424B5 Matinas BioPharma Holdin -13.1%

3/9 Q4/2019 12/31/2019 EPS -0.040 ZacksConsensus -0.030 ActVsEst (0.010) - Miss -13.0%

1/10 Form 8-K Matinas BioPharma Holdin For: Jan 09 -10.3%

1/7 Here's Why Matinas BioPharma Shares Lost as Much as 16.9% Today [The Motley Fool] -9.4%

3/31 Matinas BioPharma Provides Comment on Impact of Vascepa® Patent Litigation on MAT9001 and Update on COVID-19 Pandemic’s Effect on Business Operations and Clinical Programs -9.0%

4/2 Form 4 Matinas BioPharma Holdin For: Mar 31 Filed by: WIKLER MATTHEW -7.5%

3/18 Form 4 Matinas BioPharma Holdin For: Mar 17 Filed by: STERN ADAM K -7.4%

5/28 Matinas BioPharma Announces Publication of MAT2203 Preclinical Cryptococcal Meningitis Data in the American Society for Microbiology Journal, mBio -6.8%

1/3 Form 4 Matinas BioPharma Holdin For: Jan 01 Filed by: MANNINO RAPHAEL J -6.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}